Breast Neoplasms: all 12,820 studies

Page 32 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Increasing African Immigrant Women's Participation in Breast Cancer ScreeningCompletedNCT04450264Not applicableResults posted
• Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBCActive, not recruitingNCT04448886Phase 2Results posted
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)CompletedNCT04436744Phase 2Results posted
• Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.CompletedNCT04432727Not applicableResults posted
• MARGetuximab Or Trastuzumab (MARGOT)Active, not recruitingNCT04425018Phase 2Results posted
• DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] DiseaseCompletedNCT04420598Phase 2Results posted
• Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good PrognosisActive, not recruitingNCT04414202Results posted
• Breast Cancer: Feasibility of an Educational InterventionCompletedNCT04396665Not applicableResults posted
• HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and OutcomesTerminatedNCT04396626Results posted
• Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination TherapyCompletedNCT04394247Results posted
• Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast CancerActive, not recruitingNCT04373031Phase 2Results posted
• A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With NeratinibCompletedNCT04366713Phase 2Results posted
• Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast CancerCompletedNCT04330040Phase 4Results posted
• Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By GenomicsTerminatedNCT04315233Phase 1Results posted
• Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast CancerTerminatedNCT04305236Phase 2Results posted
• A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast CancerTerminatedNCT04298918Phase 1/2Results posted
• BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)TerminatedNCT04296942Phase 1Results posted
• Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast CancerCompletedNCT04294225Phase 2Results posted
• Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer PatientsActive, not recruitingNCT04293393Phase 2Results posted
• A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast CancerActive, not recruitingNCT04288089Phase 1Results posted
• Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without TislelizumabCompletedNCT04276493Phase 1/2Results posted
• Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast CancerActive, not recruitingNCT04272801Phase 2Results posted
• Altering Lipids for Tolerance of Aromatase Inhibitor TherapyCompletedNCT04268134Phase 2Results posted
• Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight WomenActive, not recruitingNCT04267796Not applicableResults posted
• Clinician Communication About Sexual HealthCompletedNCT04262219Not applicableResults posted
• Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility StudyCompletedNCT04261153Not applicableResults posted
• Pink Warrior 2: Teleconference-based Gaming SupportCompletedNCT04259905Not applicableResults posted
• Enhancing Cancer Prevention and Control Pathways-Native Health InitiativeCompletedNCT04259762Not applicableResults posted
• Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT StudyTerminatedNCT04256941Phase 2Results posted
• Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer PatientsCompletedNCT04256512Not applicableResults posted
• [18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular CarcinomaTerminatedNCT04252859Phase 2Results posted
• Pembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor ProgressionTerminatedNCT04251169Phase 2Results posted
• LYT-100 in Patients With BCRLTerminatedNCT04243837Phase 2Results posted
• A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Active, not recruitingNCT04225117Phase 2Results posted
• Phase 2a Study of ZW25 in Combination With Palbociclib Plus FulvestrantCompletedNCT04224272Phase 2Results posted
• Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN AlterationsTerminatedNCT04216472Phase 2Results posted
• A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 StudyActive, not recruitingNCT04215146Phase 2Results posted
• Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol)CompletedNCT04213365Not applicableResults posted
• A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT04191499Phase 2/3Results posted
• Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast CancerTerminatedNCT04191382Phase 2Results posted
• Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast CancerTerminatedNCT04190056Phase 2Results posted
• A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast CancerCompletedNCT04177108Phase 3Results posted
• CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast CancerActive, not recruitingNCT04176848Phase 2Results posted
• Real-world Treatment Patterns and Effectiveness of Palbociclib and AI TherapyCompletedNCT04176354Results posted
• mHealth Behavioral Cancer Pain Intervention for Medically Underserved PatientsCompletedNCT04175639Not applicableResults posted
• Prospective Randomized Study of Accelerated Radiation Therapy (PRART)Active, not recruitingNCT04175210Phase 3Results posted
• A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced MalignanciesTerminatedNCT04172597Phase 2Results posted
• PET/MR in Surgical Planning for Breast CA Treated With Neoadj ChemoTerminatedNCT04149353Not applicableResults posted
• 3-D Super Resolution Ultrasound Microvascular ImagingTerminatedNCT04136912Phase 2Results posted
• Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast CancerCompletedNCT04131933Results posted
• Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMBCompletedNCT04129346Not applicableResults posted
• The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast CancerCompletedNCT04129216Phase 2Results posted
• Sitravatinib in Metastatic Breast CancerTerminatedNCT04123704Phase 2Results posted
• Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast CancerCompletedNCT04111510Phase 2Results posted
• Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03CompletedNCT04109391Phase 3Results posted
• Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast CancerCompletedNCT04109066Phase 3Results posted
• Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast CancerTerminatedNCT04108858Phase 1/2Results posted
• Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer PatientsCompletedNCT04106609Not applicableResults posted
• Association of Hepatitis C Virus With Breast CancerCompletedNCT04090164Results posted
• Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerCompletedNCT04081389Phase 1Results posted
• Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or TamoxifenCompletedNCT04080297Phase 1Results posted
• A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast CancerCompletedNCT04075604Phase 2Results posted
• A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema PatientsTerminatedNCT04073823Not applicableResults posted
• A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Participants With ER+/HER2- Locally Advanced or Metastatic Breast CancerCompletedNCT04072952Phase 1/2Results posted
• RANKL Inhibition and Mammographic Breast DensityActive, not recruitingNCT04067726Phase 2Results posted
• A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast CancerTerminatedNCT04060862Phase 1Results posted
• Symptom Management for YA Cancer SurvivorsCompletedNCT04035447Not applicableResults posted
• LY3023414 and Prexasertib in Metastatic Triple-negative Breast CancerCompletedNCT04032080Phase 2Results posted
• A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast CancerTerminatedNCT04031885Phase 4Results posted
• A Study of TAS-120 in Patients With Metastatic Breast CancerTerminatedNCT04024436Phase 2Results posted
• A Study of Serum Folate Levels in Patients Treated With OlaparibCompletedNCT04024254Phase 4Results posted
• Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or TrastuzumabCompletedNCT04023110Phase 1Results posted
• Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate ReconstructionCompletedNCT04016376Phase 4Results posted
• Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthCompletedNCT04000880Not applicableResults posted
• Telephone Support for Metastatic Breast Cancer PatientsCompletedNCT03998618Not applicableResults posted
• Sexual Health Empowerment for Women's HealthActive, not recruitingNCT03984695Not applicableResults posted
• A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer PatientsActive, not recruitingNCT03983382Results posted
• HeartPhone Cancer Survivors Trial 2019TerminatedNCT03953326Phase 1/2Results posted
• Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT03941730Phase 2Results posted
• Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast CancerActive, not recruitingNCT03939897Phase 1Results posted
• Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsCompletedNCT03935282Not applicableResults posted
• Coping Together After Breast CancerCompletedNCT03930797Not applicableResults posted
• UK Ibrance Patient Program (IPP) StudyCompletedNCT03921866Results posted
• A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast CancerCompletedNCT03916744Phase 1Results posted
• Optimizing Functional Recovery of Breast Cancer SurvivorsCompletedNCT03915548Not applicableResults posted
• A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast CancerTerminatedNCT03901469Phase 2Results posted
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast CancerCompletedNCT03901339Phase 3Results posted
• Evaluating New Surgical Technique in Management of Female Patients With Operable Multifocal Breast CancerStatus unknownNCT03900299Not applicableResults posted
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsActive, not recruitingNCT03899792Phase 1/2Results posted
• Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast CancerCompletedNCT03887130Phase 2Results posted
• Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast CancerActive, not recruitingNCT03879577Phase 2Results posted
• Aromatase Inhibitor and Durvalumab in Postmenopausal Breast CancerTerminatedNCT03874325Phase 2Results posted
• Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant ChemotherapyTerminatedNCT03872388Phase 2Results posted
• Individualizing Surveillance Mammography for Older Breast Cancer SurvivorsCompletedNCT03865654Not applicableResults posted
• Automated Method for Breast Cancer DetectionTerminatedNCT03863522Not applicableResults posted
• PROactive Evaluation of Function to Avoid CardioToxicityTerminatedNCT03862131Phase 2Results posted
• Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast CancerCompletedNCT03853707Phase 1/2Results posted
• Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer PatientsCompletedNCT03847311Phase 2Results posted
• Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast CancerCompletedNCT03839823Phase 2Results posted
• Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer SurvivorsCompletedNCT03837496Not applicableResults posted

← Breast Neoplasms overview